To investigate pregestational cardiometabolic disturbances and their association with hypertensive disorders of pregnancy (HDP) in nulliparous women, highlighting the significance of addressing rising HDP rates.
Key Findings:
HDP affects 5% to 15% of pregnancies and poses long-term cardiovascular risks, emphasizing the need for early identification.
Pregestational cardiometabolic disturbances may be linked to increased risk of HDP, suggesting a need for targeted interventions.
Elevated fasting glucose and triglyceride levels, along with reduced HDL-C, were noted as potential risk factors, warranting further investigation.
Interpretation:
Identifying cardiometabolic risk factors before conception could enhance prevention strategies for HDP, potentially leading to improved maternal and neonatal outcomes.
Limitations:
Variability in study design and biomarker thresholds may affect findings, and potential biases in data collection should be considered.
The study primarily included older nulliparous women, limiting generalizability to younger populations.
Conclusion:
A stronger evidence base for early prevention of HDP is needed, focusing on pregestational cardiometabolic health and the importance of early intervention.